Vaccine adjuvant based on a cd40 ligand

Details Vaccine adjuvant based on a cd40 ligand Vaccine adjuvant based on a cd40 ligand

A - Human Necessities

61

K

A61K 39/39 (2006.01) A61K 39/095 (2006.01) A61K 39/102 (2006.01) A61K 39/12 (2006.01) A61K 39/145 (2006.01) A61K 39/395 (2006.01) C07K 14/035 (2006.01) C07K 14/16 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2509776

We describe a conjugate comprising a CD40 ligand and an antigen wherein said conjugate has adjuvant activity and particularly, but not exclusively, the use of the conjugate in vaccination against vital diseases or conditions which result from viral infection.

L'invention se rapporte à un conjugué contenant un ligand CD40 et un antigène, ledit conjugué présentant une activité adjuvante, et en particulier, mais de façon non limitative, à l'utilisation du conjugué dans la vaccination contre des maladies ou troubles viraux résultant d'une infection virale.

Affiliated with

Also associated with

Rating

Vaccine adjuvant based on a cd40 ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine adjuvant based on a cd40 ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine adjuvant based on a cd40 ligand will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2032139